Style | Citing Format |
---|---|
MLA | Varnamkhasti TJ, et al.. "Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y)." Pharmacological Reports, vol. 74, no. 4, 2022, pp. 769-. |
APA | Varnamkhasti TJ, Jafarzadeh M, Sadeghizadeh M, Aghili M (2022). Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y). Pharmacological Reports, 74(4), 769-. |
Chicago | Varnamkhasti TJ, Jafarzadeh M, Sadeghizadeh M, Aghili M. "Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y)." Pharmacological Reports 74, no. 4 (2022): 769-. |
Harvard | Varnamkhasti TJ et al. (2022) 'Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y)', Pharmacological Reports, 74(4), pp. 769-. |
Vancouver | Varnamkhasti TJ, Jafarzadeh M, Sadeghizadeh M, Aghili M. Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y). Pharmacological Reports. 2022;74(4):769-. |
BibTex | @article{ author = {Varnamkhasti TJ and Jafarzadeh M and Sadeghizadeh M and Aghili M}, title = {Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y)}, journal = {Pharmacological Reports}, volume = {74}, number = {4}, pages = {769-}, year = {2022} } |
RIS | TY - JOUR AU - Varnamkhasti TJ AU - Jafarzadeh M AU - Sadeghizadeh M AU - Aghili M TI - Correction To: Radiosensitizing Effect of Dendrosomal Nanoformulation of Curcumin on Cancer Cells (Pharmacological Reports, (2022), 74, 4, (718-735), 10.1007/S43440-022-00383-Y) JO - Pharmacological Reports VL - 74 IS - 4 SP - 769 EP - PY - 2022 ER - |